Skip to main content

Lung cancer survival rate - Stage 2 lung cancer


When a person looks for a medical professional about the stage 2 lung cancer, one of the first
questions that come to mind is: what is my lung cancer survival rate? This is largely influenced by the medical records showing that lung cancer is one of the lowest chances of survival of cancers in the world. One must realize that these statistics are only numbers and a variety of factors that can affect your chances of being cured.

The lung cancer survival rate is affected by several variables. One such variable is age.
Younger people tend to have a greater chance of survival for people over 50. This is due to the
strong natural defenses younger than the older. Medical records also indicate that women with lung cancer in stage 2 have a greater ability to be cured of their male counterparts the parties.


The spread of malignant tumor is a very important factor in determining the survival of lung cancer
exchange rate. The tumors may spread from the lung tissues to lymph nodes. When the lymph nodes
affected by cancer cells, a low survival rate of a little more. Continue to smoke even after being diagnosed with Stage 2 lung cancer greatly reduce one's ratio of being cured for Smoking increases curing toxins infused into the lungs.

Complications such as blood clots in the lungs would be a major obstacle in one's quest to be cured Lung cancer. In general, the overall health of the person is a major determinant of whether one is have a higher lung cancer survival rate or not.

Advances in technology today not only in detecting and determining the degree of cancer, but also to facilitate healing and appropriate methods of treatment are a major reasons for the Phase 2 rates lung cancer survival are beginning to climb. From now on, the year 5 survival rate of a person with Stage 2 lung cancer is 40 percent chance of cure at 50 and this could increase further if the patient has a very good physical condition - natural and defenses.

One should not fear at diagnosis of a terminal illness like cancer. He or she must remember that the key to surviving one of the greatest challenges of life have to face immediately to the early detection the better the chances of survival and cure.

Labels

Labels:

Popular posts from this blog

Analysis: Life saving lung cancer test to set off cost debate

By Bill Berkrot NEW YORK | Wed Jun 29, 2011 6:07pm EDT NEW YORK (Reuters) - A landmark study showing that routine lung screening of heavy smokers and former smokers using low dose CT scans could save thousands of lives is sure to set off a fierce debate about the cost of such testing on an overburdened healthcare system. The U.S. National Cancer Institute studied more than 53,000 people between the ages of 55 and 74 deemed at high risk of developing lung cancer. It found that screening with the three-dimensional X-rays cut deaths by 20 percent. Details of the study and a discussion of its implications were published on Wednesday in the New England Journal of Medicine, lending additional weight to initial findings that were released in November. The discussion noted that radiologists using more advanced CT equipment than was available for the study could lead to an even larger reduction in lung cancer deaths. At the same time, the potential for many more false positive results could ri...
Read more

Alternative Pain Therapy for Breast, Prostate and Lung Cancer

Alternative Pain Therapy for Breast, Prostate and Lung Cancer MIAMI--(Healthcare Sales & Marketing Network)-- Bio-Nucleonics? lead product Strontium Chloride Sr-89 Injection USP (Strontium-89), which is the generic version of Metastron?, is an option to consider for metastatic cancer bone pain therapy, typically caused by advanced stage breast, prostate or lung cancer. Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in patients with painful skeletal metastases. In the body, Strontium acts similar to calcium and is preferentially taken up in osteoblastic tissue while the unabsorbed isotope is excreted in the urine the first 2 to 3 days following injection, clearing rapidly from the blood and selectively localizing in bone mineral. Uptake of strontium by bone occurs preferentially in sites of active osteogenesis; thus primary bone tumors and areas of metastatic involvement (blastic lesions) can accumulate significa...
Read more